These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37753088)

  • 21. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
    Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
    Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GEM-PA-Based Subunit Vaccines of Crimean Congo Hemorrhagic Fever Induces Systemic Immune Responses in Mice.
    Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Bi J; Jiao C; Li E; Wang T; Wang J; Jin H; Huang P; Yan F; Yang S; Xia X
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and phylogenetic analysis of Crimean-Congo hemorrhagic fever virus in ticks collected from Punjab province of Pakistan.
    Shahid MF; Yaqub T; Ali M; Ul-Rahman A; Bente DA
    Acta Trop; 2021 Jun; 218():105892. PubMed ID: 33753031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions.
    Al-Abri SS; Abaidani IA; Fazlalipour M; Mostafavi E; Leblebicioglu H; Pshenichnaya N; Memish ZA; Hewson R; Petersen E; Mala P; Nhu Nguyen TM; Rahman Malik M; Formenty P; Jeffries R
    Int J Infect Dis; 2017 May; 58():82-89. PubMed ID: 28259724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.
    Saunders JE; Gilbride C; Dowall S; Morris S; Ulaszewska M; Spencer AJ; Rayner E; Graham VA; Kennedy E; Thomas K; Hewson R; Gilbert SC; Belij-Rammerstorfer S; Lambe T
    EBioMedicine; 2023 Apr; 90():104523. PubMed ID: 36933409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus.
    Spengler JR; Estrada-Peña A; Garrison AR; Schmaljohn C; Spiropoulou CF; Bergeron É; Bente DA
    Antiviral Res; 2016 Nov; 135():31-47. PubMed ID: 27713073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in research on Crimean-Congo hemorrhagic fever.
    Papa A; Mirazimi A; Köksal I; Estrada-Pena A; Feldmann H
    J Clin Virol; 2015 Mar; 64():137-43. PubMed ID: 25453328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
    Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
    Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meeting report: First International Conference on Crimean-Congo hemorrhagic fever.
    Papa A; Weber F; Hewson R; Weidmann M; Koksal I; Korukluoglu G; Mirazimi A
    Antiviral Res; 2015 Aug; 120():57-65. PubMed ID: 26022198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
    Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
    Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies.
    Dai S; Deng F; Wang H; Ning Y
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice.
    Leventhal SS; Meade-White K; Shaia C; Tipih T; Lewis M; Mihalakakos EA; Hinkley T; Khandhar AP; Erasmus JH; Feldmann H; Hawman DW
    EBioMedicine; 2024 Mar; 101():105017. PubMed ID: 38382314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crimean-Congo hemorrhagic fever.
    Whitehouse CA
    Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.
    Omoniyi AA; Adebisi SS; Musa SA; Nzalak JO; Bauchi ZM; Bako KW; Olatomide OD; Zachariah R; Nyengaard JR
    Sci Rep; 2022 May; 12(1):8736. PubMed ID: 35610299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods.
    Li H; Smith G; Goolia M; Marszal P; Pickering BS
    Virol J; 2023 Jun; 20(1):128. PubMed ID: 37337294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
    Dowall SD; Graham VA; Rayner E; Hunter L; Watson R; Taylor I; Rule A; Carroll MW; Hewson R
    PLoS One; 2016; 11(6):e0156637. PubMed ID: 27272940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of functional epitopes of structural proteins and in-silico designing of dual acting multiepitope anti-tick vaccine against emerging Crimean-Congo hemorrhagic fever virus.
    Shrivastava N; Verma A; Dash PK
    Eur J Pharm Sci; 2020 Aug; 151():105396. PubMed ID: 32479862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment.
    Maltezou HC; Papa A
    BMC Med; 2011 Dec; 9():131. PubMed ID: 22152109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.